Market Landscaping and Sizing

A winning strategy requires deep understanding of the size, growth, segmentation, competitive dynamics, and voice-of-customer in your markets. DeciBio has the qualitative and quantitative research and analysis capabilities to give you the insights you need.

Our Experts

Stephane Budel

Andrew Aijian

Miguel Edwards

Carl Schoellhammer

Carl Schoellhammer

Schedule a Call

Related Client Results

All Client Results

Pharma & Biotech

Internal Lab Buildout Strategy

A large pharmaceutical company engaged DeciBio to evaluate strategies for an internal build of a lab to support clinical and commercial opportunities in oncology

Voice-of-Customer Research

Due Diligence

Pre-due Diligence Research on a Potential Acquisition Target

A multi-billion dollar life science company needed pre diligence on a potential acquisition target

Competitive Analysis

Due Diligence

Target Identification

VOC research, competitive assessment for a novel multi-omic technology

A ~$100M research tools and diagnostic company wanted to understand key applications and revenue potential of their novel technology to inform a go / no-go development decision

Pricing Strategy

Voice-of-Customer Research

Competitive Analysis

Market Landscaping and Sizing

Novel Technology Commercialization

Financial Services

PE-Backed Life Sciences Tools Platform Development

A leading private equity firm and management team sought out DeciBio as a strategic partner to advise on the life sciences market and perform due-diligences in support of the development of a novel life sciences tools platform

Voice-of-Customer Research

Customer Segmentation

Pricing Strategy

Due Diligence

Competitive Analysis

Pharma & Biotech

Clinical, Genomic, and Pathology Real-World Data (RWD) Market Landscape Assessment

A real-world data (RWD) provider wanted to identify key use cases, unmet needs, and future opportunities in the RWD market, with a particular focus on clinical, genomic, and pathology RWD and biopharma users.

Voice-of-Customer Research

Pricing Strategy

Competitive Analysis

Clinical Diagnostics

RNA-based Oncology Biomarker Market Landscape

A cancer diagnostics company wanted to understand the current and future landscape for RNA-based oncology biomarkers, focusing on gene expression profiling (GEP) and rearrangements across medical settings

Voice-of-Customer Research

Competitive Analysis

Biomarker and Diagnostics Strategy

Product Specification Mapping

Precision Medicine is evolving at a rapid pace

Discover how we can help